Lung Cancer Update for Oncology Nurses A Continuing Education (CE) Audio Series Activity

HOW TO USE THIS MONOGRAPH

This CE activity contains both audio and print components. This monograph contains edited comments, clinical trial schemas, graphics and references that supplement the audio program.

LungCancerUpdate.com/Nurses includes an easy-to-use interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other web resources indicated here in red underlined text. There are no fees for participating and receiving CE credit for this activity. To receive credit during the period of May 2004 through May 2005, participants should read the learning objectives and faculty disclosures, listen to the CDs or tapes, review the monograph and complete the post-test and evaluation form located in the back of this monograph or on the LungCancerUpdate.com/Nurses website and mail or fax the evaluation form to the Postgraduate Institute for Medicine.

STATEMENT OF NEED/TARGET AUDIENCE

Lung cancer is the leading cause of cancer mortality in the United States in both men and women. Chemotherapy, surgery and radiation therapy have had a modest effect on patient outcomes; however, recent improvements have been seen in time to progression and survival in lung cancer clinical trials. Research findings and ongoing clinical trials lead to the continuous emergence of new drugs and therapies and changes in the indications for existing treatments. To offer their patients the best care possible, nurses need to be aware of ongoing research and changes in cancer care so as to include the widening array of therapeutic options for cancer patients into their everyday patient management decisions. To assist with meeting this need, Lung Cancer Update for Oncology Nurses provides an overview of the latest research developments in lung cancer and the opinions of oncology nurses, patients and research leaders with experience and expertise in the field.

GOAL STATEMENT

To present the most current research developments in lung cancer and their impact on nursing care strategies.

EDUCATIONAL OBJECTIVES FOR THIS ISSUE OF LUNG CANCER UPDATE FOR ONCOLOGY NURSES

Upon completion of this activity, participants should be able to:

• Describe the types and stages of lung cancer and the stage-based modalities utilized in the treatment of lung cancer.
• Discuss nursing management of disease-related symptoms and treatment side effects.
• Describe gefitinib therapy including mechanism of action, side effects and nursing implications.
• Discuss key clinical trials in lung cancer in the adjuvant and metastatic setting.
• Discuss social stigma related to lung cancer and the impact on patients and healthcare professionals.
• Describe nursing interventions based on the biopsychosocial model in caring for patients with lung cancer.

ACCREDITATION STATEMENTS

This educational activity for 3.3 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

California Board of Registered Nursing

The Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 3.3 contact hours.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within three weeks.

There is no fee for this educational activity.